发明授权
US07504382B2 Protease inhibitors for coronaviruses and SARS-CoV and the use thereof
失效
用于冠状病毒和SARS-CoV的蛋白酶抑制剂及其用途
- 专利标题： Protease inhibitors for coronaviruses and SARS-CoV and the use thereof
- 专利标题（中）： 用于冠状病毒和SARS-CoV的蛋白酶抑制剂及其用途
-
申请号： US10839753申请日： 2004-05-06
-
公开(公告)号： US07504382B2公开(公告)日： 2009-03-17
- 发明人: Sui Xiong Cai , William E. Kemnitzer , Hong Zhang , Han-Zhong Zhang
- 申请人： Sui Xiong Cai , William E. Kemnitzer , Hong Zhang , Han-Zhong Zhang
- 申请人地址： US CA San Diego
- 专利权人： Cytovia, Inc.
- 当前专利权人： Cytovia, Inc.
- 当前专利权人地址： US CA San Diego
- 代理机构： Sterne, Kessler, Goldstein & Fox P.L.L.C.
- 主分类号： A61K38/00
- IPC分类号： A61K38/00
摘要：
Disclosed are protease inhibitors for coronaviruses and SARS-CoV, or picornaviruses, and the use of these protease inhibitors for preventing, reducing, ameliorating and treating a disease or condition caused by coronaviruses and SARS-CoV, or picornaviruses. Also disclosed are methods of reducing or preventing the spread of coronavirus, or picornaviruses, and preventing or reducing the replication of coronavirus, or picornaviruses, with the compounds of the present invention.
公开/授权文献
信息查询
IPC分类:
